Telegram
InVivo Therapeutics Holdings Corp. NVIV
$ 0.31
-37.48%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиInVivo Therapeutics Holdings Corp. Мультипликаторы 2011-2024 | NVIV
Мультипликаторы по годам InVivo Therapeutics Holdings Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.3 | -1.3 | -0.6 | -0.2 | -0.4 | -0.7 | -6.2 | -3.5 | -9.4 | -4.4 | 28.3 | -3.1 |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-6.8 | -7.5 | -1.3 | -35.3 | -140.8 | -20.3 | -0.8 | -1.3 | -0.2 | -0.5 | 0.1 | -0.7 |
EV (Enterprise Value) |
-10.1 млн | -2.47 млн | -11.1 млн | -445 тыс. | -6.01 млн | 9.15 млн | 130 млн | 107 млн | 170 млн | 160 млн | 138 млн | 139 млн |
EBITDA per Share |
-6.89 | -7.45 | -1.8 | -33.3 | -76.2 | -551 | -568 | -615 | -580 | -741 | -589 | -492 |
EV/EBITDA |
-28.6 | 1.5 | 0.4 | 0.6 | -0.3 | -5.3 | -4.5 | -9.5 | -8.7 | -9.7 | -12.1 | |
PEG |
-0.02 | -0.09 | -0.01 | -0.0 | -0.0 | 0.1 | -0.16 | 0.07 | -0.16 | 0.01 | 0.26 | 0.02 |
P/B |
0.2 | 0.7 | 0.3 | 0.4 | 0.5 | 1.8 | 5.0 | 6.9 | 29.3 | 13.2 | -57.2 | -3.4 |
P/CF |
-0.3 | -1.5 | -0.6 | -0.2 | -0.7 | -0.9 | -8.7 | -7.2 | -11.3 | -10.9 | -10.7 | -13.9 |
ROE % |
-66.62 | -54.62 | -47.29 | -211.89 | -145.39 | -264.54 | -80.96 | -196.79 | -310.00 | -300.67 | -201.86 | 111.45 |
ROA % |
-55.73 | -45.45 | -41.41 | -126.86 | -127.46 | -190.42 | -67.38 | -152.87 | -109.90 | -226.69 | 29.04 | -609.03 |
ROCE % |
-67.64 | -54.65 | -45.63 | -172.58 | -78.95 | -224.94 | -80.38 | -121.20 | -237.28 | -128.17 | 1751.61 | 27.90 |
Current Ratio |
6.1 | 6.0 | 10.0 | 2.5 | 7.8 | 4.4 | 7.0 | 6.3 | 1.6 | 6.4 | 0.8 | 0.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально InVivo Therapeutics Holdings Corp.
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.87 | -0.62 | -0.85 | - | -1.98 | -1.97 | -1.94 | - | -1.79 | -1.68 | -1.89 | - | -0.47 | -0.49 | -2.47 | - | -8.63 | -10.13 | -8.49 | - | -0.42 | -7.48 | -3.34 | - | -6.99 | -4.92 | -4.98 | - | -0.19 | -0.16 | -0.24 | - | -0.09 | -0.39 | -0.64 | - | -0.01 | -0.17 | -0.28 | - | -0.07 | -0.2 | -0.2 | - | 0.12 | 0.03 | 0.05 | - | 0.06 | -0.03 | -0.02 |
EBITDA per Share |
-0.91 | -0.67 | -0.9 | - | -2 | -1.96 | -1.94 | - | -1.76 | -1.67 | -1.87 | - | -0.46 | -0.49 | -2.48 | - | -8.66 | -10.4 | -8.9 | - | -0.27 | -1.59 | -3.34 | - | -4.43 | -5.17 | -5.09 | - | -0.17 | -0.17 | -0.19 | - | -0.2 | -0.2 | -0.21 | - | -0.15 | -0.2 | -0.26 | - | -0.06 | -0.07 | -0.04 | - | -0.04 | -0.04 | -0.04 | - | -0.04 | -0.05 | -0.03 |
ROE % |
-91.57 | -88.61 | -93.10 | -65.62 | -77.32 | -61.74 | -50.42 | -30.32 | -42.20 | -42.37 | -43.88 | -35.87 | -83.85 | -119.96 | -164.87 | -151.50 | -171.20 | -142.92 | -166.92 | -129.71 | -222.20 | -294.97 | -277.37 | -218.41 | -239.81 | -168.73 | -123.93 | -62.19 | -75.82 | -68.05 | -111.83 | -168.83 | -189.33 | -196.19 | -196.11 | -168.33 | -210.51 | -232.20 | -281.42 | -256.39 | -603.91 | -909.24 | -893.67 | -579.11 | -588.95 | -251.28 | -151.62 | -1.34 | -9.84 | 4.40 | 4.10 |
ROA % |
-78.20 | -70.68 | -73.08 | -51.87 | -62.26 | -52.03 | -44.06 | -27.37 | -37.77 | -37.78 | -38.82 | -31.41 | -60.14 | -78.47 | -102.19 | -90.70 | -107.98 | -96.53 | -133.22 | -113.72 | -180.29 | -229.58 | -204.32 | -157.22 | -175.03 | -126.27 | -96.03 | -51.76 | -62.35 | -55.13 | -88.14 | -131.15 | -138.42 | -135.10 | -109.02 | -59.68 | -91.48 | -116.02 | -177.74 | -193.31 | -143.33 | -61.54 | 35.73 | 83.30 | 137.09 | 140.89 | 103.16 | 7.35 | 53.79 | -24.03 | -22.41 |
ROCE % |
-95.92 | -91.94 | -95.23 | -66.21 | -77.93 | -61.91 | -50.51 | -30.34 | -42.23 | -42.42 | -43.95 | -35.99 | -84.93 | -121.96 | -168.70 | -156.87 | -169.98 | -134.17 | -93.44 | -60.56 | -123.03 | -172.39 | -223.44 | -196.94 | -217.25 | -175.08 | -126.56 | -59.52 | -94.19 | -108.55 | -122.59 | -101.25 | -171.96 | -208.01 | -254.06 | -236.48 | -278.43 | -249.66 | -208.93 | -103.41 | 19.55 | 184.46 | 343.05 | 348.72 | 355.82 | 239.96 | 128.83 | 19.71 | 7.10 | 8.11 | 4.50 |
Current Ratio |
14.4 | 7.6 | 7.2 | 6.1 | 4.1 | 4.9 | 6.1 | 6.0 | 9.0 | 10.3 | 12.8 | 8.0 | 8.0 | 8.0 | 8.0 | 2.5 | 2.5 | 2.5 | 2.5 | 8.1 | 8.1 | 8.1 | 8.1 | 3.6 | 3.6 | 3.6 | 3.6 | 6.0 | 6.0 | 6.0 | 6.0 | 4.5 | 4.5 | 4.5 | 4.5 | 1.6 | 1.6 | 1.6 | 1.6 | 4.1 | 4.1 | 4.1 | 4.1 | 0.9 | 0.9 | 0.9 | 0.9 | 0.1 | 0.1 | 0.1 | 0.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD